Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

A VUMC study found that following up with patients within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction.
April 12, 2022

Financial impact of prior authorization

Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.

By Leigh MacMillan
March 31, 2022

Clip In 4 the Cure

More than 300 riders participated in the inaugural Clip In 4 the Cure, a relay-style, team cycling event that supported cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By VUMC News and Communications
March 31, 2022

Black patients with cancer face worse COVID outcomes: study

Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

By Tom Wilemon
March 24, 2022

Stress in young adult cancer patients and caregivers

Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being.

By Leigh MacMillan
March 24, 2022

Berlin named interim leader of Hematology and Oncology

Jordan Berlin, MD, has been appointed interim leader of Vanderbilt’s Division of Hematology and Oncology in the Department of Medicine.

By Tom Wilemon
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt’s Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

By Tom Wilemon
March 11, 2022

New Clinician Spotlight: Jeffrey Tosoian

Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan.
By VUMC News and Communications
March 10, 2022

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.
By Leah Mann 
March 9, 2022

Research Staff Awards honor those who help drive science forward

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony.
By Bill Snyder
March 9, 2022

Martin shares colorectal cancer story, urges early detection

Vanderbilt Wilson County Hospital's Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer.
By Tom Wilemon
March 7, 2022

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease
By Tom Wilemon
February 24, 2022

Melanoma treatment response

Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found.
By Sarah E. Glass
February 17, 2022

Park named director of Vanderbilt-Ingram Cancer Center

Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.
By John Howser
1 … 6 7 8 9 10 … 58